Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses

Respiratory Research

Volumn 14, Issue 1, 2013, Pages

  Bochkov, Yury A ^a   Busse, William W ^a   Brockman Schneider, Rebecca A ^a   Evans, Michael D ^b   Jarjour, Nizar N ^a   McCrae, Christopher ^c   Miller Larsson, Anna ^c   Gern, James E ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Bronchial epithelial cells; Budesonide; Formoterol; Human rhinovirus

Indexed keywords

BETA1 INTERFERON; BUDESONIDE; FORMOTEROL; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 28; INTERLEUKIN 8; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; BRONCHODILATING AGENT; CYTOKINE; ETHANOLAMINE DERIVATIVE;

ADULT; AIRWAY; ALLERGIC ASTHMA; ARTICLE; BRONCHUS MUCOSA; CELL CULTURE; CLINICAL ARTICLE; COLONY FORMING UNIT; CYTOKINE RESPONSE; DISEASE EXACERBATION; DRUG EFFECT; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; MALE; PROTEIN EXPRESSION; PROTEIN SECRETION; RHINOVIRUS; UPREGULATION; VIRUS REPLICATION; ASTHMA; BRONCHUS; CASE CONTROL STUDY; DRUG COMBINATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PICORNAVIRUS INFECTION; VIROLOGY;

ADULT; ASTHMA; BRONCHI; BRONCHODILATOR AGENTS; BUDESONIDE; CASE-CONTROL STUDIES; CHEMOKINE CXCL10; CYTOKINES; DRUG THERAPY, COMBINATION; EPITHELIAL CELLS; ETHANOLAMINES; FEMALE; HUMANS; MALE; MIDDLE AGED; PICORNAVIRIDAE INFECTIONS; RHINOVIRUS; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 84884942387     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-14-98     Document Type: Article

References (35)

1. Friedlander SL, Busse WW. The role of rhinovirus in asthma exacerbations. J Allergy Clin Immunol 2005, 116:267-273. 10.1016/j.jaci.2005.06.003, 16083778.
2. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L, et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. BMJ 1995, 310:1225-1229. 10.1136/bmj.310.6989.1225, 2549614, 7767192.
3. Wells KE, Peterson EL, Ahmedani BK, Severson RK, Gleason-Comstock J, Williams LK. The relationship between combination inhaled corticosteroid and long-acting beta-agonist use and severe asthma exacerbations in a diverse population. J Allergy Clin Immunol 2012, 129:1274-1279. 10.1016/j.jaci.2011.12.974, 3340459, 22281166.
4. Chung KF, Caramori G, Adcock IM. Inhaled corticosteroids as combination therapy with beta-adrenergic agonists in airways disease: present and future. Eur J Clin Pharmacol 2009, 65:853-871. 10.1007/s00228-009-0682-z, 19557399.
5. Bateman ED, Harrison TW, Quirce S, Reddel HK, Buhl R, Humbert M, et al. Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps. Respir Res 2011, 12:38. 10.1186/1465-9921-12-38, 3082240, 21463522.
6. Reddel HK, Jenkins C, Quirce S, Sears MR, Bateman ED, OByrne PM, et al. Effect of different asthma treatments on risk of cold-related exacerbations. Eur Respir J 2011, 38:584-593. 10.1183/09031936.00186510, 21406510.
7. Silvestri M, Serpero L, Petecchia L, Sabatini F, Cerasoli F, Rossi GA. Cytokine-activated bronchial epithelial cell pro-inflammatory functions are effectively downregulated in vitro by ciclesonide. Pulm Pharmacol Ther 2006, 19:210-217. 10.1016/j.pupt.2005.05.006, 16084120.
8. Sabatini F, Silvestri M, Sale R, Serpero L, Raynal ME, Di BP, et al. Modulation of the constitutive or cytokine-induced bronchial epithelial cell functions in vitro by fluticasone propionate. Immunol Lett 2003, 89:215-224. 10.1016/S0165-2478(03)00142-1, 14556981.
9. Grunberg K, Sharon RF, Hiltermann TJ, Brahim JJ, Dick EC, Sterk PJ, et al. Experimental rhinovirus 16 infection increases intercellular adhesion molecule-1 expression in bronchial epithelium of asthmatics regardless of inhaled steroid treatment. Clin Exp Allergy 2000, 30:1015-1023. 10.1046/j.1365-2222.2000.00854.x, 10848925.
10. Spurrell JC, Wiehler S, Zaheer RS, Sanders SP, Proud D. Human airway epithelial cells produce IP-10 (CXCL10) in vitro and in vivo upon rhinovirus infection. Am J Physiol Lung Cell Mol Physiol 2005, 289:L85-L95. 10.1152/ajplung.00397.2004, 15764644.
11. Schroth MK, Grimm E, Frindt P, Galagan DM, Konno SI, Love R, et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 1999, 20:1220-1228. 10.1165/ajrcmb.20.6.3261, 10340941.
12. Kirchberger S, Majdic O, Stockl J. Modulation of the immune system by human rhinoviruses. Int Arch Allergy Immunol 2007, 142:1-10. 10.1159/000095993, 17016053.
13. Kallal LE, Lukacs NW. The role of chemokines in virus-associated asthma exacerbations. Curr Allergy Asthma Rep 2008, 8:443-450. 10.1007/s11882-008-0084-9, 18682112.
14. Edwards MR, Johnson MW, Johnston SL. Combination therapy: synergistic suppression of virus-induced chemokines in airway epithelial cells. Am J Respir Cell Mol Biol 2006, 34:616-624. 10.1165/rcmb.2005-0385OC, 16424382.
15. Davies JM, Carroll ML, Li H, Poh AM, Kirkegard D, Towers M, et al. Budesonide and formoterol reduce early innate anti-viral immune responses in vitro. PLoS One 2011, 6:e27898. 10.1371/journal.pone.0027898, 3220700, 22125636.
16. Gustafson LM, Proud D, Hendley JO, Hayden FG, Gwaltney JM. Oral prednisone therapy in experimental rhinovirus infections. J Allergy Clin Immunol 1996, 97:1009-1014. 10.1016/S0091-6749(96)80077-7, 8655877.
17. DeMore JP, Weisshaar EH, Vrtis RF, Swenson CA, Evans MD, Morin A, et al. Similar colds in subjects with allergic asthma and nonatopic subjects after inoculation with rhinovirus-16. J Allergy Clin Immunol 2009, 124:245-52. 252, 10.1016/j.jaci.2009.05.030, 2737589, 19596142.
18. Bochkov YA, Hanson KM, Keles S, Brockman-Schneider RA, Jarjour NN, Gern JE. Rhinovirus-induced modulation of gene expression in bronchial epithelial cells from subjects with asthma. Mucosal Immunol 2010, 3:69-80. 10.1038/mi.2009.109, 2884103, 19710636.
19. Lee WM, Wang WS, Rueckert RR. Complete sequence of the RNA genome of human rhinovirus 16, a clinically useful common cold virus belonging to the ICAM-1 receptor group. Virus Genes 1995, 9:177-181. 10.1007/BF01702661, 7732663.
20. Mosser AG, Vrtis R, Burchell L, Lee WM, Dick CR, Weisshaar E, et al. Quantitative and qualitative analysis of rhinovirus infection in bronchial tissues. Am J Respir Crit Care Med 2005, 171:645-651. 10.1164/rccm.200407-970OC, 15591468.
21. Sherry B, Rueckert R. Evidence for at least two dominant neutralization antigens on human rhinovirus 14. J Virol 1985, 53:137-143. 254989, 2981332.
22. He JQ, Sandford AJ, Wang IM, Stepaniants S, Knight DA, Kicic A, et al. Selection of housekeeping genes for real-time PCR in atopic human bronchial epithelial cells. Eur Respir J 2008, 32:755-762. 10.1183/09031936.00129107, 18417509.
23. Holgate ST, Roberts G, Arshad HS, Howarth PH, Davies DE. The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. Proc Am Thorac Soc 2009, 6:655-659. 10.1513/pats.200907-072DP, 20008870.
24. Korn SH, Jerre A, Brattsand R. Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells. Eur Respir J 2001, 17:1070-1077. 10.1183/09031936.01.00073301, 11491146.
25. Skevaki CL, Christodoulou I, Spyridaki IS, Tiniakou I, Georgiou V, Xepapadaki P, et al. Budesonide and formoterol inhibit inflammatory mediator production by bronchial epithelial cells infected with rhinovirus. Clin Exp Allergy 2009, 39:1700-1710. 10.1111/j.1365-2222.2009.03307.x, 19549024.
26. Strandberg K, Palmberg L, Larsson K. Effect of budesonide and formoterol on IL-6 and IL-8 release from primary bronchial epithelial cells. J Asthma 2008, 45:201-203. 10.1080/02770900801890372, 18415826.
27. Wark PA, Johnston SL, Bucchieri F, Powell R, Puddicombe S, Laza-Stanca V, et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201:937-947. 10.1084/jem.20041901, 2213100, 15781584.
28. Contoli M, Message SD, Laza-Stanca V, Edwards MR, Wark PA, Bartlett NW, et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12:1023-1026. 10.1038/nm1462, 16906156.
29. Lopez-Souza N, Favoreto S, Wong H, Ward T, Yagi S, Schnurr D, et al. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J Allergy Clin Immunol 2009, 123:1384-1390. 10.1016/j.jaci.2009.03.010, 2744461, 19428098.
30. Wark PA, Bucchieri F, Johnston SL, Gibson PG, Hamilton L, Mimica J, et al. IFN-gamma-induced protein 10 is a novel biomarker of rhinovirus-induced asthma exacerbations. J Allergy Clin Immunol 2007, 120:586-593. 10.1016/j.jaci.2007.04.046, 17628646.
31. Gern JE. The ABCs of rhinoviruses, wheezing, and asthma. J Virol 2010, 84:7418-7426. 10.1128/JVI.02290-09, 2897627, 20375160.
32. Papi A, Contoli M, Adcock IM, Bellettato C, Padovani A, Casolari P, et al. Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor kappaB and c-Jun N-terminal kinase activation. J Allergy Clin Immunol 2013, (in press) http://dx.doi.org/10.1016/j.jaci.2013.05.028.
33. Korpi-Steiner NL, Valkenaar SM, Bates ME, Evans MD, Gern JE, Bertics PJ. Human monocytic cells direct the robust release of CXCL10 by bronchial epithelial cells during rhinovirus infection. Clin Exp Allergy 2010, 40:1203-1213. 10.1111/j.1365-2222.2010.03546.x, 2909328, 20545701.
34. Kato A, Favoreto S, Avila PC, Schleimer RP. TLR3- and Th2 cytokine-dependent production of thymic stromal lymphopoietin in human airway epithelial cells. J Immunol 2007, 179:1080-1087. 2220044, 17617600.
35. Mosser AG, Brockman-Schneider RA, Amineva SP, Burchell L, Sedgwick JB, Busse WW, et al. Similar frequency of rhinovirus-infectable cells in upper and lower airway epithelium. J Infect Dis 2002, 185:734-743. 10.1086/339339, 11920291.